[Federal Register Volume 67, Number 175 (Tuesday, September 10, 2002)]
[Notices]
[Pages 57430-57431]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-22895]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-02-77]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.

[[Page 57431]]

    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. CDC is requesting an emergency 
clearance from the Office of Management and Budget (OMB) to collect 
data under the Public Health Security and Bioterrorism Preparedness and 
Response Act of 2002. Send comments to Anne O'Connor, CDC Assistant 
Reports Clearance Officer, 1600 Clifton Road, MS D-24, Atlanta, GA 
30333. Written comments should be received within 14 days of this 
notice. OMB is expected to act on the request of CDC within 21 days of 
publication of this notice.
    Proposed Project: Minimum Data Elements (MDE) and System for 
Technical Assistance Reporting (STAR) for the National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP)--New--The National 
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 
Centers for Disease Control and Prevention (CDC). The NBCCEDP was 
established in response to the Congressional Breast and Cervical Cancer 
Mortality Prevention Act of 1990 to provide early detection, breast and 
cervical cancer screening services for under-served women. The CDC 
proposes to aggregate breast and cervical cancer screening, diagnostic 
and treatment data from NBCCEDP grantees at the state, territory and 
tribal level. These aggregated data will include demographic 
information about women served through funded programs. The proposed 
data collection will also include infrastructure data about grantee 
management, public education and outreach, professional education, and 
service delivery.
    Breast cancer is a leading cause of cancer-related death among 
American women. The American Cancer Society estimates that 203,500 new 
cases will be diagnosed among women in 2002, and 39,600 women will die 
of this disease. Mammography is extremely valuable as an early 
detection tool because it can detect breast cancer well before the 
woman can feel the lump, when it is still in an early and more 
treatable stage. Women older than age 40 that receive annual 
mammography screening reduce their probability of breast cancer 
mortality and increase their treatment options.
    Although early detection efforts have greatly decreased the 
incidence of invasive cervical cancer during the last four decades, an 
estimated 13,000 new cases will be diagnosed in 2002 and 4,100 women 
will die of this disease. Papanicolaou (Pap) tests effectively detect 
precancerous lesions in addition to invasive cervical cancer. The 
detection and treatment of precancerous lesions can prevent nearly all 
cervical cancer-related deaths.
    Because breast and cervical cancer screening, diagnostic and 
treatment data are already collected and aggregated at the state, 
territory and tribal level, the additional burden on the grantees will 
be small. Implementation of this program will require grantees to 
report a minimum data set electronically to the CDC on a semi-annual 
basis. The program will require grantees to report infrastructure data 
to the CDC annually using a web-based system. Information collected 
will be used to obtain more complete breast and cervical cancer data, 
promote public education of cancer incidence and risk, improve the 
availability of screening and diagnostic services for under-served 
women, ensure the quality of services provided to women, and develop 
outreach strategies for women that are never or rarely screened for 
breast and cervical cancer. There are no costs to respondents.

----------------------------------------------------------------------------------------------------------------
                                                                            Number of     Average
                                                               Number of    responses    burden per     Total
                            Form                              respondents      per        response   burden  (in
                                                                            respondent    (in hrs)       hrs)
----------------------------------------------------------------------------------------------------------------
Infrastructure report (STAR)................................           71            1           25        1,775
Screening and follow-up (MDE)...............................           71            2            4          568
                                                             --------------
    Total...................................................  ...........  ...........  ...........        2,343
----------------------------------------------------------------------------------------------------------------


    Dated: September 3, 2002.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-22895 Filed 9-9-02; 8:45 am]
BILLING CODE 4163-18-P